(322 days)
Not Found
Not Found
No
The provided text describes the intended use of the device but contains no mention of AI, ML, or related concepts like image processing, training sets, or performance metrics typically associated with AI/ML devices.
Yes
The device is intended for "symptomatic relief and management of chronic intractable pain," "relaxation of muscle spasms," and "increasing local blood circulation," which are all therapeutic uses.
No
Explanation: The device is described for "symptomatic relief and management of chronic intractable pain," "relaxation of muscle spasms," and other therapeutic applications, not for diagnosing conditions.
No
The provided text only describes the intended use of the device and does not contain a device description. The intended use describes a device that provides symptomatic relief and management of pain and muscle-related issues, which typically involves hardware components for electrical stimulation or other physical modalities. Without a device description, it is impossible to confirm if it is software-only.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended uses described for the ELPHA devices (symptomatic relief of pain, muscle relaxation, etc.) are all related to treating or managing conditions within the body.
- IVD Definition: In Vitro Diagnostics are devices used to examine specimens (like blood, urine, or tissue) outside of the body to provide information for diagnosis, monitoring, or screening.
The ELPHA devices are clearly designed for therapeutic purposes applied directly to the patient's body, not for analyzing samples in a lab setting.
N/A
Intended Use / Indications for Use
ELPHA // 500, ELPHA // 1000
This Danmeter device is designed for the symptomatic relief and management of chronic intractable pain and as an adjunct in the management of post-surgical pain and post traumatic acute pain.
ELPHA // 2000
This Danmeter device is designed for the relaxation of muscle spasms, prevention or retardation of disuse atrophy, increasing local blood circulation, muscle re-education, immediate post-surgical stimulation of calf muscles to prevent venous thrombosis and maintaining or increasing range of motion.
ELPHA II 3000
This Danmeter device is designed for:
- Symptomatic relief and management of chronic (long-term), intractable pain and as an adjunct in the management of post-surgical pain and post traumatic acute pain.
- Relaxation of muscle spasms, prevention or retardation of disuse atrophy, increasing local blood circulation, muscle re-education, immediate post-surgical stimulation of calf muscles to prevent venous thrombosis and maintaining or increasing range of motion.
Product codes (comma separated list FDA assigned to the subject device)
IPF, GZJ
Device Description
Not Found
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Not Found
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Not Found
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 890.5850 Powered muscle stimulator.
(a)
Identification. A powered muscle stimulator is an electrically powered device intended for medical purposes that repeatedly contracts muscles by passing electrical currents through electrodes contacting the affected body area.(b)
Classification. Class II (performance standards).
0
DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is an abstract symbol resembling an eagle or bird, composed of three curved lines.
Public Health Service
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
AUG - 9 2004
Mr. Hanne Neilsen Quality Manager Danmeter A/S Kildemosevej 13 DK-5000 Odense C Denmark
Re: K032954
K032934
Trade Name: Elpha, Models II 500, II 1000, II 1000, II 2000 and II 3000 Trade Name: - Epine, 21 CFR 890.5850, 21 CFR 882.5890 Regulation Name: 21 CFR 070.5650, 21 OF F 0826 - 1
Regulation Name: Powered muscle stimulator, Transcutaneous electrical nerve stimulator for pain relief Regulatory Class: II Product Code: IPF, GZJ Dated: July 2, 2004 Received: July 8, 2004
Dear Mr. Neilsen:
We have reviewed your Section 510(k) premarket notification of intent to market the indication We have reviewed your Section 910(x) premained institution of the indications
referenced above and have determined the device is substantially interests a for use stated in the enclosure) the arranted the arranted predicate devices marketed in interstate for use stated in the encrosule, to regary manated promote and the Federal Food. Drug commerce prior to May 28, 1970, the chartinent anit of the Federal Food, Drug, devices that have been reclassified in accordance whiles proval application (PMA).).
and Cosmetic Act (Act) that do not require approval of a presisions of the Act . The and Cosment Act (Act) that to not require apple the general controls provisions of the Act. The Act. The You may, therefore, market the device, economics for annual registration, listing of general Controls provisions of the free labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), in class san If your device is classified (seculority) me existing major regulations affecting your device can
may be subject to such additional controls. Existing major may be subject to such additional controlis. Existing may organ In addition, FDA may
be found in the Code of Federal Regulations, Title 21, Parts 800 to 899, Inc. and be found in the Oous of reasts concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean Please be advised that FDA s issualles of a succession and other requirements of the Act
that FDA has made a determination that your device complies with other may to that FDA has made a delectimation that your as roo by other Federal agencies. You must or any Federal statutes and regulations administered by of his its increasing increasing and listing (21
comply with all the Act's requirements, including, but not limited to CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set CFK Part 807), labeling (21 CFR Part 800); go a name (20); and 1f applicable, the electronic (2006); for the electronic (200 forth in the quality systems (Sections 531-542 of the Act); 21 CFR 1000-1050.
1
Page 2 – Mr. Hanne Neilsen
This letter will allow you to begin marketing your device as described in your Section 510(k) This letter will allow you to begin maketing your dovice of your device to a legally
premarket notification. The FDA finding of substantial equivalence of your device premarket notification. The FDA inding of substantial equivation of your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please
rs the results of the most on 1650 - All any desse note the regulation enti If you desire specific advice for your de necesses in assessment the regulation entitled, the may obtain contact the Office of Complance at (501) 591 1077 (21CFR Patt 807.97). You may obtain "Misbranding by reference to premarket nonlineauon" (1998) from the Division of Small
other general information on your responsibilities under the Act from number (800) 638-2 other general information on your responsion.com its toll-free number (800) 638-2041 or
Manufacturers, International and Consumer Assistance at its toll-Armanain html Manufacturers, International and Consultive Pressonal Prosessor of thinksmaldsmamain.html
Sincerely yours,
Mark A. Milken
Celia M. Witten, Ph.D., M.D. Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known): K032954
Device Name: ELPHA
Indications for Use:
ELPHA // 500, ELPHA // 1000
This Danmeter device is designed for the symptomatic relief and management of chronic Trills Danneler device is dosigned for the symption the management of post-surgical pain and post traumatic acute pain.
ELPHA // 2000
This Danmeter device is designed for the relaxation of muscle spasms, prevention or This Danmeler device to doolghou resing local blood circulation, muscle re-education, retardator of diddod at oping hation of calf muscles to prevent venous thrombosis and maintaining or increasing range of motion.
ELPHA II 3000
This Danmeter device is designed for:
- Symptomatic relief and management of chronic (long-term), intractable pain and an . Oymptomation one and the management of post-surgical pain and post traumatic acute pain.
- Relaxation of muscle spasms, prevention or retardation of disuse atrophy, increasing . local blood circulation, muscle re-education, immediate post-surgical stimulation of lood blood croates to prevent venous thrombosis and maintaining or increasing range of motion.
rt 21 CFR 801 Subpart D)
AND/OR
Over-The-Counter Use (21 CFR 807 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Page __ of __